Congress is being urged to pass the Biosimilar Red Tape Elimination Act to reduce medication costs by removing the costly interchangeability standard for biologics.
Congress is being urged to pass the Biosimilar Red Tape Elimination Act to reduce medication costs by removing the costly interchangeability standard for biologics.
Login
